DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation

DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation

Atrial fibrillation (AF) and coronary artery disease requiring percutaneous coronary intervention (PCI) and stenting often coexist in older patients. This poses the difficult problem of concurrent anticoagulant and double antiplatelet therapy (triple therapy). Current treatment guidelines do recomm...

Full description

Bibliographic Details
Main Authors:	Mauro Di Bari, Alessandra Pratesi, Francesca M. Nigro, Irene Marozzi, Stefano Fumagalli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2018-06-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Dual anti-platelet therapy triple therapy acute coronary syndrome atrial fibrillation older patients hemorrhagic vs thromboembolic risk.
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/957

Similar Items

Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF)
by: Lisa Riesinger, et al.
Published: (2021-08-01)

Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
by: Paweł Bogacki, et al.
Published: (2016-11-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation
by: N. Z. Gasymova, et al.
Published: (2019-05-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Anticoagulation therapy in older patients at risk for syncopal and not-syncopal fall and/or frailty. An AcEMC-GIMSI multidisciplinary consensus document
by: Ivo Casagranda, et al.
Published: (2020-03-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

THE UNRESOLVED ISSUES AND MODERN VIEW ON ATRIAL FIBRILLATION PATIENTS MANAGEMENT
by: D. V. Losik, et al.
Published: (2017-08-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017-05-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used
by: Francesco Orso, et al.
Published: (2013-12-01)

Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
by: Bo Eun Park, et al.
Published: (2020-10-01)

Antithrombotic treatments for patients with atrial fibrillation and a requirement for a coronary artery stent
by: Andrew.Owen
Published: (2013-01-01)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
by: Soo Min Jang, et al.
Published: (2020-03-01)

Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01)

Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
by: Natale Daniele Brunetti, et al.
Published: (2020-08-01)

Anticoagulation in patients with atrial fibrillation and coronary artery disease
by: Fahad Abdullah Alkindi, et al.
Published: (2020-01-01)

Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients
by: Masahiko Umei, MD, et al.
Published: (2017-10-01)

The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
by: EL Dolgova, et al.
Published: (2014-12-01)

Oral anticoagulant therapy in atrial fibrillation older patients with previous bleeding
by: Mario Bo, et al.
Published: (2020-03-01)

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
by: Rose Mary Ferreira Lisboa Da Silva, et al.
Published: (2019-01-01)

The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
by: Zheng HJ, et al.
Published: (2017-03-01)

Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation
by: Masahide Harada, et al.
Published: (2020-06-01)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
by: Seongwook Han, et al.
Published: (2021-10-01)

Antiplatelet therapy is not a safer alternative to oral anticoagulants, even in older hospital-discharged patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2016-10-01)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
by: Lili Wei, et al.
Published: (2020-07-01)

Anticoagulant therapy and components of the metabolic syndrome in patients with atrial fibrillation in real outpatient clinical practice
by: V. A. Ionin, et al.
Published: (2019-04-01)

Prevalence, morphologic characteristic and predictors of organization of atrial auricle thrombi four weeks after anticoagulant preparation to scheduled electrical cardioversion of atrial fibrillation
by: Kalashnykova O.S.
Published: (2013-10-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Su-Kiat Chua, et al.
Published: (2020-04-01)

Anticoagulant therapy in patients with atrial fibrillation and an implanted cardiac resynchronization therapy device
by: M. A. Kirgizova, et al.
Published: (2021-05-01)

ATRIAL FIBRILLATION IN PATIENTS WITH HEMORRHAGIC STROKE: APPROACHES TO ANTICOAGULANT THERAPY
by: A. M. Kulagina, et al.
Published: (2017-05-01)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
by: Benhur Davi Henz, et al.